Boston Scientific (LTS:0HOY) Cyclically Adjusted FCF per Share: $1.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HOY Boston Scientific Corp LTS:0HOY
77 GF Score
Price $45.01
GF Value $104.78
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Cyclically Adjusted FCF per Share?

Boston Scientific LTS:0HOY +4.05% 77 Cyclically Adjusted FCF per Share is $1.07 as of Mar. 2026. GuruFocus rates LTS:0HOY with a GF Score™ of 77/100 and a GF Value™ of $104.78 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Boston Scientific's adjusted free cash flow per share for the three months ended in Mar. 2026 was $0.114. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $1.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Boston Scientific's average Cyclically Adjusted FCF Growth Rate was 22.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Boston Scientific was 39.60% per year. The lowest was -15.20% per year. And the median was 5.70% per year.

As of today (2026-07-17), Boston Scientific's current stock price is $45.01. Boston Scientific's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $1.07. Boston Scientific's Cyclically Adjusted Price-to-FCF of today is 42.07.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Boston Scientific was 129.40. The lowest was 40.95. And the median was 69.75.


Boston Scientific  (LTS:0HOY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Boston Scientific's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=45.01/1.07
=42.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Boston Scientific was 129.40. The lowest was 40.95. And the median was 69.75.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Boston Scientific Cyclically Adjusted FCF per Share Related Terms


Boston Scientific Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Cyclically Adjusted FCF per Share Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.68 0.74 0.82 1.07

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.96 1.00 1.07 1.07

LTS:0HOY vs EW, GEHC, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted Price-to-FCF falls into.


LTS:0HOY
77GF Score
Boston Scientific Corp LTS:0HOY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.114/330.2130*330.2130
=0.114

Current CPI (Mar. 2026) = 330.2130.

Boston Scientific Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.253 241.018 0.347
201609 -0.074 241.428 -0.101
201612 0.272 241.432 0.372
201703 -0.106 243.801 -0.144
201706 0.151 244.955 0.204
201709 0.251 246.819 0.336
201712 0.403 246.524 0.540
201803 0.021 249.554 0.028
201806 -0.347 251.989 -0.455
201809 0.277 252.439 0.362
201812 -0.079 251.233 -0.104
201903 0.184 254.202 0.239
201906 0.081 256.143 0.104
201909 0.254 256.759 0.327
201912 0.455 256.974 0.585
202003 -0.127 258.115 -0.162
202006 0.123 257.797 0.158
202009 0.345 260.280 0.438
202012 0.451 260.474 0.572
202103 0.146 264.877 0.182
202106 0.375 271.696 0.456
202109 0.249 274.310 0.300
202112 0.148 278.802 0.175
202203 -0.131 287.504 -0.150
202206 0.140 296.311 0.156
202209 0.208 296.808 0.231
202212 0.417 296.797 0.464
202303 0.048 301.836 0.053
202306 0.310 305.109 0.336
202309 0.334 307.789 0.358
202312 0.467 306.746 0.503
202403 -0.055 312.332 -0.058
202406 0.394 314.175 0.414
202409 0.469 315.301 0.491
202412 0.780 315.605 0.816
202503 0.186 319.799 0.192
202506 0.734 322.561 0.751
202509 0.730 324.800 0.742
202512 0.628 324.054 0.640
202603 0.114 330.213 0.114

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $1.07 mean?
Boston Scientific (LTS:0HOY) has a Cyclically Adjusted FCF per Share of $1.07 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Cyclically Adjusted FCF per Share too high?
Boston Scientific's current Cyclically Adjusted FCF per Share is $1.07. Overall, Boston Scientific has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Cyclically Adjusted FCF per Share compare to EW and GEHC?
Boston Scientific's Cyclically Adjusted FCF per Share of $1.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Boston Scientific and its competitors. Boston Scientific's current Cyclically Adjusted FCF per Share is $1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (LTS:0HOY) is currently considered Significantly Undervalued. The stock's GF Value™ is $104.78, compared to a current price of $45.01 — trading 57% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $1.07. Boston Scientific's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Boston Scientific (LTS:0HOY), the current Cyclically Adjusted FCF per Share is $1.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (LTS:0HOY) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of $45.01 is trading 57% below its estimated GF Value™ of $104.78. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for LTS:0HOY:

  • Cyclically Adjusted FCF per Share: $1.07
  • GF Value™: $104.78 vs. price of $45.01 (57% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the LTS:0HOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
77GF Score

Get the complete analysis for LTS:0HOY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.01
Price
$104.78
GF Value